Icosapent Ethyl
20 NDCs across 12 manufacturers|18 Generic,2 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 26, 2012, and the first generic was approved May 21, 2020. FDA's Orange Book lists 21 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $868 million on Icosapent Ethyl across 2.0 million claims for 478,000 beneficiaries.
Icosapent Ethyl is available as 20 NDCs from 12 manufacturers (18 generic, 2 brand), with NADAC prices from $0.33 to $2.84 per EA — the most expensive product costs about 8.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
20
18G / 2B
Manufacturers
12
competing in market
Price Spread
$0.33 – $2.84
per EA
7d Activity
avg +0.6% WoW · of 20 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amarin Pharma Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
12 manufacturers producing ICOSAPENT ETHYL(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VASCEPA 1 GM CAPSULE | $2.8366 per EA | — |
VASCEPA 0.5 GM CAPSULE | $1.6611 per EA | — |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 1 GRAM CAPSULE | $0.4408 per EA | -0.13% |
ICOSAPENT ETHYL 0.5 GM CAPSULE | $0.3342 per EA | +2.49% |
ICOSAPENT ETHYL 0.5 GM CAPSULE | $0.3342 per EA | +2.49% |
ICOSAPENT ETHYL 0.5 GM CAPSULE | $0.3342 per EA | +2.49% |
ICOSAPENT ETHYL 0.5 GM CAPSULE | $0.3342 per EA | +2.49% |
ICOSAPENT ETHYL 500 MG CAPSULE | $0.3342 per EA | +2.49% |
ICOSAPENT ETHYL 0.5 GM CAPSULE | $0.3316 per EA | — |
Frequently Asked Questions
When did Icosapent Ethyl become available as a generic?
FDA approved the first generic Icosapent Ethyl (ANDA) on May 21, 2020. The Orange Book currently lists 21 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Icosapent Ethyl?
In 2024, Medicare Part D spent $868 million on Icosapent Ethyl across 2.0 million claims for 478,000 beneficiaries.
How many Icosapent Ethyl products are on the market?
The Icosapent Ethyl drug market contains 20 NDCs from 12 manufacturers — 18 generic and 2 brand products.
What is the price range for Icosapent Ethyl?
NADAC reference prices for Icosapent Ethyl range from $0.3316 to $2.8366 per EA — the most expensive product costs about 8.6× the cheapest.
Is generic Icosapent Ethyl cheaper than brand?
The average generic NADAC for Icosapent Ethyl is $0.4051 per EA, versus $2.2488 for brand-labeled products — brand versions average about 5.6× the generic price.
Which manufacturers make Icosapent Ethyl?
12 manufacturers list Icosapent Ethyl in NADAC. Ranked by number of NDCs, the largest are Amarin Pharma Inc. (2), NorthStar Rx LLC (2), Teva Pharmaceuticals USA Inc. (2), Hikma Pharmaceuticals USA Inc. (2), Amneal Pharmaceuticals LLC (2).
How has the price of Icosapent Ethyl changed recently?
Over the past 7 days, 5 Icosapent Ethyl NDCs rose and 12 fell, with a market-wide average change of +0.6%.